Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Apr 1.
Published in final edited form as: Biochemistry. 2025 Mar 18;64(7):1636–1645. doi: 10.1021/acs.biochem.4c00668

Coarse-Grained Simulations of Phosphorylation Regulation of p53 Autoinhibition

Shrishti Barethiya 1,#, Samantha Schultz 1,2,#, Yumeng Zhang 1, Jianhan Chen 1,2,*
PMCID: PMC12410095  NIHMSID: NIHMS2108264  PMID: 40101966

Abstract

Intrinsically disordered proteins (IDPs) are key components of cellular signaling and regulatory networks. They frequently remain dynamic even in complexes and thus rely on potentially subtle shifts in the disordered conformation ensemble for function. Understanding the molecular basis of these fascinating mechanisms of IDP function and regulation requires detailed characterization of dynamic ensembles in various biologically relevant states. Here, we study the phosphorylation dependence of the dynamic interaction between the N-terminal transactivation domain (NTAD) and DNA-binding domain (DBD) of tumor suppressor p53, which plays a key role in autoinhibition and regulation of p53 activation or termination during various stages of stress response. By extending the hybrid-resolution (HyRes) coarse-grained (CG) protein force field to model phosphorylated sidechains, we show that HyRes simulations accurately recapitulate the effects of phosphorylation on the p53 NTAD/DBD interactions. The simulated ensembles show that phosphorylation of Thr55 as well as Ser46 enhances dynamic NTAD/DBD interactions and further induces conformational shifts that promote trans interactions between two p53 dimers to drive dissociation from DNA. These CG simulations thus provide a strong molecular basis in support of previous experimental studies suggesting the central role of dynamic interactions of disordered domains and phosphorylation in function of p53. Success of the current study also suggests that HyRes provides an efficient and viable tool for studying dynamic interactions and post-translational modifications in IDPs function and regulation.

Introduction

Intrinsically disordered proteins (IDPs) play crucial roles in cellular regulation and signaling13 and are frequently associated with various human diseases4. Unlike structured proteins, IDPs lack a stable tertiary structure under physiological conditions, primarily due to their low sequence complexity that is generally enriched with charged and hydrophilic residues13. Unbound IDPs exist as dynamic and presumably heterogeneous ensemble of disordered conformations with various degrees of secondary structure propensities. Upon specific binding, IDPs often undergo binding-induced folding transitions58. It has also been recognized that IDPs can remain unstructured even in specific complexes and functional assemblies914. The dynamic nature of the disordered ensembles in the unbound and often bound states arguably allows IDPs to respond sensitively to various cellular stimuli, such as the binding of ligands and cofactors, changes in cellular environments, and post-translational modifications1518. Multiple cellular signals can be naturally integrated through cooperative responses of the entire dynamic ensemble1921. To understand these fascinating mechanisms of IDP function and regulation, we need to integrate experiment and molecular modeling to resolve the molecular detail of dynamic ensembles of IDPs under various biologically relevant states.

The tumor suppressor protein p53 is considered one of the most important proteins in cancers and plays a central role in cellular stress responses22,23. The full-length p53 protein is composed of several distinct domains as shown in Figure 1A, including an intrinsically disordered N-terminal transactivation domain (NTAD) and proline-rich domain (PRD), a structured DNA-binding domain (DBD), a short disordered region containing the nuclear localization signal (NLS), a folded tetramerization domain (TET), and a disordered C-terminal regulatory domain (CTD)24. While DBD directly binds with specific genes for transcription activation activities, disordered domains interact with numerous proteins from various signaling pathways that regulate the p53 level and activity2528. The p53 NTAD, in particular, is one of the most studied IDPs with nontrivial transient local and long-range structural features2933 (Figure 1B). It is characterized by two activation motifs, AD1 and AD2, which have substantial residual helical propensities and can fold into short helices in various complexes3437. The disordered nature of NTAD is considered an essential property for p53’s role as a major hub protein5,8. How the disordered ensemble responds to multi-site phosphorylation and cancer-associated mutations arguably governs the preference of p53 interactions with various cofactors that ultimately control its stability and activity27,28,38,39.

Figure 1. Sequence and structure of p53.

Figure 1.

A) Function domains of p53. Residue S121 in DBD is the paramagnetic spin labelling site in PRE experiments42. B) Sequence of p53 NTAD. Negatively charged residues are colored in blue. C) The structure of p53 tetramer, which is a dimer of dimers (colored in gray and cyan). For the monomer on the top left, the PRD and NTAD are colored in green and red, respectively. The negatively charged NTAD residues and positively charged DBD residues are highlighted using blue and red beads, respectively. The two key phosphorylation sites studied here (Ser46 and Thr55) are also labeled in panels B and C.

Besides mediating numerous intermolecular interactions, negatively charged NTAD also interacts dynamically with the positively charged DNA-binding interface of DBD and competes with DNA for binding to DBD40,41. This intramolecular interaction is regulated by phosphorylation and contributes to the control of p53 activation or termination during various stages of stress response42. NMR experiments show that phosphorylation of Thr55 in AD2 enhances the binding of NTAD to DBD and disrupts cooperative binding to p53-specific DNA targets, especially those with weaker p53 binding affinities42. The autoinhibition is further enhanced by phosphorylation of Ser46, leading to biphasic behavior in the concentration dependence of DNA binding as assessed by fluorescence anisotropy42. Dephosphorylation of Thr55 by protein phosphatase 2A releases the autoinhibition and activates the transcription during damage of DNA4345. At late stages of DNA damage, Thr55 would be re-phosphorylated by TAF1 kinase to drive DNA disassociation and terminate the stress responses46. While these experiments have firmly established the role of Thr55 phosphorylation as a master switch to activate or terminate p53-mediated transcription activities, much remains to be known about how phosphorylation regulates the dynamic NTAD/DBD interaction at the molecular level.

Paramagnetic relaxation enhancement (PRE) measurements suggest that pThr55 and pSer46 mainly enhance the interactions of the AD2 of NTAD with DBD42. However, these experiments do not resolve NTAD/DBD interactions within the same monomer or between NTAD of one monomer with DBD of another within the dimer or tetramer of p53. It has been speculated that the ability to form interactions within the same dimer (cis) across the dimer-dimer interface (trans) may provide the molecular basis of regulation by Thr55 (and Ser46) phosphorylation42 (Figure 1C). Further resolving this mechanism requires molecular dynamics (MD) simulations to generate the disordered ensembles of p53 and examine how phosphorylation may shift the conformational equilibrium4751. Such a task is computationally too demanding for atomistic MD simulations given the large system size and complexity of conformational space. Instead, coarse-grained (CG) models that dramatically reduce the system size and extend the accessible length and timescales are desired52.

We have previously developed a hybrid-resolution (HyRes) force field specifically designed to describe disordered conformational ensembles of IDPs5355. In HyRes, the protein backbone is represented atomistically whereas side chains are represented with single or multiple CG beads (Figure 2A). The covalent parameters and side chain CG bead size were parameterized based on atomistic simulations to maximally reproduce the covalent geometry and flexibility, which can be important in accurate describing packing at the protein-protein interface. The effective energy function of HyRes also includes backbone hydrogen-bonding, Debye-Hückel electrostatics, and van de Waals (vdW) interactions, parameterized based on to reproduce pair-wise backbone and side chain interactions as well as the helical propensities and chain dimension of small model IDPs. The latest HyRes model, implemented on GPU, can provide a semi-quantitative description of secondary structures as well as long-range interactions of a set of IDPs55. It has been successfully applied to study the dynamic interactions of several proteins including phase separation with success14,5456. Therefore, HyRes may provide an effective balance between accuracy and computational efficiency to elucidate the molecular basis of how phosphorylation regulates the dynamic interactions between p53 NTAD and DBD.

Figure 2. HyRes modeling of phosphorylated serine and threonine.

Figure 2.

A) HyRes representation of all natural or canonical residues, which includes atomistic backbone and intermediate-resolution side chains. B) Mapping of phosphorylated Ser and Thr residues. The blue bead represents the phosphate group (bead CC). C) Distributions of the CB-CC bond length and D) CA-CB-CC bond angle in HyRes (blue traces) in comparison to those derived from atomistic simulations (red).

In this work, we have simulated the wild-type and phosphorylated p53 tetramers using the HyRes force field to study the molecular mechanism of the p53 autoinhibition. The generated conformational ensembles were validated by comparing to the available NMR PRE experimental data42. This was followed by detailed conformational analysis to examine how various local and long-range conformational properties of NTAD as well as the dynamic NTAD/DBD interaction depended on phosphorylation of Thr55 and Ser46. The results provide a detailed description of how pThr55 and pSer46 enhance AD2-DBD interactions and promote the trans mode of NTAD/DBD interactions within the tetramer for autoinhibition. This study shows that HyRes can capture complex IDP dynamic interactions and provides an important tool for molecular simulations of disordered proteins and understanding their roles in function and diseases.

Materials and Methods

Parameterization for Phosphorylated Sidechains

To model the effects pThr55 and pSer46 on p53, we first developed an HyRes model for phosphorylated serine and threonine, by including an additional CC bead for the phosphate group (Figure 2B). The CC bead carries −1 net charge. The parametrization of bond, angle and vdW parameters followed the HyRes convention53,54 (also summarized above). We first performed 100-ns atomistic simulations of serine and threonine dipeptides in CHARMM2257 with GBSW implicit solvent58. The equilibrium pseudo bond lengths (CA-CB and CB-CC) and bond angle (CA-CB-CC) were set to the averaged values in the all-atom simulations (Table 1). The bond and angle force constants kb and kθ were set using the standard deviations derived from GBSW trajectories, such that the CG model would roughly reproduce the flexibility of these sidechains in atomistic simulations. The vdW radii of CC beads were set to reproduce the volume of the corresponding group of atoms from atomistic representation, whereas ε was taken form that of the glutamate acid side chain bead (Table 2). For the CB bead of pSer, εi and vdW radius were taken from those of alanine; for pThr CB, the vdW parameters were taken as the average of alanine and valine CB values. The distributions of the bonds and angles of the phosphorylated serine and threonine dipeptides calculated from 20 ns trajectories using the above HyRes model are shown in Figure 2C and 2D, in comparison to those derived from GBSW simulations. The results show that HyRes is able to reproduce the covalent geometry and flexibility for both pSer and pThr.

Table 1.

Bonded parameters of phosphorylated residues, kb/kθ in kcal/mol, b0 in Å, and θo in °.

Bond/Angle k b /k θ b0o Bond/Angle k b /k θ b0o
pSer CA-CB 262.9 1.61 pSer N-CA-CB 20.0 110.3
pSer CB-CC 200.0 2.53 pSer CA-CB-CC 20.0 132.8
pThr CA-CB 200.0 2.03 pThr C-CA-CB 20.0 101.2
pThr CB-CC 200.0 3.20 pThr N-CA-CB 20.0 98.4
pSer C-CA-CB 20.0 112.3 pThr CA-CB-CC 20.0 72.6

Table 2.

vdW parameters of pSer and pThr side chains. The CC bead has −1.0 net charge.

Bead type εi (kcal/mol) vdW radii (Å)
pSer CB −0.15 2.12
pThr CB −0.22 2.44
pSer and pThr CC −0.07 2.25

MD Simulation Protocols

To construct the initial structural model of p53 tetramer, we first mapped the X-ray structure of the p53 DBD tetramer (PDB ID: 3KMD59) onto HyRes representation using the “at2hyres” script (https://github.com/mdlab-um/HyRes_GPU). A disordered conformation of NTAD and PRD (residues 1–94) was generated using CHARMM60,61 and then attached to p53 DBD using MODELLER62. The C-terminal domains after DBD were not included in the current study. The tetramer structure was then used to initiate a high-temperature simulation at 800 K to randomize the N-terminal domain structures. The p53 DBD C⍺ atoms were harmonically restrained with a force constant of 1.0 kcal/(mol Å2). In addition, pulling forces were imposed on the N-termini during high-temperature simulations to generate random conformations with various degrees of separation between NTAD from DBD. The final set of 8 initial conformations of the tetramer are shown in Figure S1. Note that using this diverse set of initial structures for independent simulations minimizes the impacts of initial structures and ensure comprehensive sampling of dynamic NTAD/DBD interactions. All production simulations were performed using CHARMM/OpenMM60,63,64 on GPU. Langevin thermostat was used with a friction coefficient of 0.2 ps−1 and reference temperature of 300 K. Lengths of all hydrogen-containing bonds were constrained by the SHAKE65 algorithm, and the MD integration time step was 4 fs. Non-bonded interactions were smoothly switched off from 1.6 to 1.8 nm. For each construct (wild type, pThr55, and pSer46 pThr55), eight replicates were run from different initial conformations (Figure S1) for 400 ns with snapshots saved every 20 ps. Atomistic ensembles of NTAD alone generated using a99SB-disp were taken from the previous work33.

Data Analysis

The generated trajectories were analyzed using in-house scripts utilizing MDAnalysis66 and MDTraj67 libraries. In all the analyses the last 300ns of the simulations are used, unless otherwise specified. The helicity probability was calculated using the standard Dictionary of Secondary Structure of Proteins (DSSP) protocol68. For the tetramer, the average helicity was calculated across all frames for the four NTAD monomers in each replica run. Subsequently, the mean and standard deviation were computed across all eight independent runs.

To validate the dynamic ensembles from HyRes simulations, theoretical PRE values were calculated between all NTAD and PRD residues and the paramagnetic labeling site (S121 in DBD42; see Figure 1A),

IoxIred=R2exp-R2sptR2+R2sp, (1)
R2sp=kr-64τc+3τc1+ωH2τc2, (2)

where r is the distance between C⍺ atoms of the paramagnetic spin-labeled residue and other residues in NTAD and PRD. The other parameters are k = 1.23 × 10−32 cm6/s2, ωH = 600 MHz, τC = 3.3 ns, R2 = 16 s−1, and t = 9.8 ms, taken from our previous work33. Note that for each snapshot of the tetramer, a total of 16 distances needs to be calculated between four monomers and four spin-labeled S121 on DBDs. The ensemble average r-6 in Eq. 2 includes all distances.

The principal component analysis (PCA) was performed utilizing the scikit-learn69 library using only C⍺ atoms of NTADs. The first two principal components were first determined using conformations pooled from all three sets of simulations (wild type, pThr55, and pSer46 pThr55). The same two principal components were then used to derive the conformational distributions of the three different constructs. All molecular visualization was prepared using VMD70.

Results and Discussion

Phosphorylation effects on p53 NTAD conformational equilibrium

To assess the ability of the coarse-grained force field to capture relevant IDP dynamics, we first compare the HyRes conformational properties with atomistic ensembles generated using a99SB-disp, one of the best explicit solvent atomistic protein force fields for IDPs33,71. As summarized in Figure 3, the radius of gyration (Rg) distributions for NTAD alone are highly consistent between HyRes and a99SB-disp (red vs blue traces), with much smaller errors indicating superior convergence with HyRes. The average Rg for NTAD is 25.8 Å in HyRes, compared well to that of 26.2 Å in a99SB-disp. HyRes also describes the helical propensities of NTAD alone well (Figure 3C), supporting that HyRes is well equipped to describe the dynamic ensemble of p53 NTAD. Note that a99SB-disp slightly over-estimates the helicity of p53 NTAD compared to the experimental results33,54, whereas HyRes interestingly better reproduce experimental distributions. Within the tetramer context, NTAD forms dynamic interactions with DBD, mainly driven by nonspecific electrostatic interactions42,54. This interaction has modest impacts on the chain dimension (Figure 3A, green vs blue traces), but appears to significantly reduce the helicity in the AD1 region (Figure 3C). Interestingly, phosphorylation of Thr55 and Ser46 has minimal impact on either the local and global structures of NTAD (Figure 3B and 3D). This is not necessarily surprising considering the transient and dynamic nature of NTAD/DBD interactions. There is only a very modest decrease in the residual helicity in the AD2 region, which is the primary region affects by phosphorylation indicated by PRE experiments42 as well as the current HyRes simulations (see below). Chemical shift analysis of the pThr55 and p53 construct also suggest no substantial perturbation except near the phosphorylation site, supporting a lack of significant changes in NTAD residual helicity42.

Figure 3. Residue helicity profiles and Rg distributions of p53 NTAD in various constructs.

Figure 3.

A) Probability distributions of Rg of NTAD calculated using HyRes (blue; NTAD alone) vs a99SB-disp (red; NTAD alone) vs HyRes (green; NTAD in tetramer). B) Probability distributions of Rg of NTAD in p53 tetramers without and with phosphorylation of Thr55 and Ser46. C) Residue helicity profiles calculated using a99SB-disp (NTAD alone) and HyRes (NTAD alone or in tetramer). D) Residue helicity profiles of NTAD in tetramers without (green: wild type) or with phosphorylation (blue: pThr55; red: pSer46pThr55) calculated using HyRes.

HyRes recapitulates the effects of phosphorylation on dynamic NTAD/DBD interactions

To determine if HyRes correctly captures long-range intramolecular interactions of p53 tetramer, we calculated the theoretical PRE profiles of the NTAD and PRD residues induced by a paramagnetic spin label on residue S121 on DBD42. PRE experiment can detect long-range transient interactions between the paramagnetic spin label and the rest of the protein up to ~ 35 Å72, and is thus uniquely suitable for critical validation of the simulated ensemble. We have previously shown that HyRes is able to reproduce the experimental PRE profiles measured on NTAD alone, at a level that is comparable to a99SB-disp54. In Figure 4 and Figure S2, we compared the PRE profile calculated from HyRes simulation of the p53 tetramer (red trace) with experimental values (red bars). There is a general agreement between the two profiles, even though there is clearly an overestimation of the contact between N-terminal segment (residues 1–25) in HyRes generated ensemble. Note that there are 6 Asp/Glue residues in this region, which is comparable to a total of 7 Asp/Glu’s within residues 40–60. As such, the N-terminus of NTAD could be expected to be similarly attractive to DBD, leading to comparable PRE effects around residues 1–25 and 40–60. The experimental observation that the N-terminal segment (especially residues 1–12) is rarely in the proximity of DBD suggests that NTAD may be stiffer than HyRes predicts, such that the entropy cost of bringing the N-terminus of NTAD to DBD should have been much greater. This may reflect a limitation of HyRes, and likely CG protein models in general.

Figure 4. Calculated and measured PRE profiles of p53 NTAD and PRD region with and without phosphorylation.

Figure 4.

The experimental profiles are shown in red (wild type) and blue (pThr55) bars. Theoretical profiles were calculated sets of 8 independent HyRes simulations (see Methods). The error bars are not shown for clarity; see Figure S2 for error bars associated with each calculated PRE profile.

We then evaluate if the simulated ensembles could recapitulate the effects of pThr55 and pSer46. The results show that HyRes correctly predicts pThr55 enhances the NTAD-DBD interaction mainly through the AD2 region, leading to significant increases in PRE effects (Figure 4, blue vs red traces compared to blue vs red bars). Interestingly, the simulated ensemble reveals that increased AD2 interactions with DBD is achieved at the expense of reduced AD1 interactions with DBD, leading to weaker PRE effects in the N-terminal region of NTAD. This is exactly what was observed experimentally (blue bars in Figure 4). The simulation thus supports the notions that AD1 and AD2 compete with each other for dynamic binding to DBD and that pThr55 shifts the balance towards AD2 binding42. Additional phosphorylation of Ser46 further strengthens the effects of pThr55, leading to stronger PRE effects in the AD region and further reduced PREs in the N-terminus (Figure 4, green trace). This is consistent with functional and physical studies of the double phosphorylated construct42. Analysis of the probabilities of direct contacts between DBD and NTAD/PRD domains show consistent trends with those observed in PRE profiles. In the AD1, the contact frequencies are higher for the wild-type and the lowest for the pSer46pThr55 construct (Figures S3A). However, AD2 exhibits higher DBD contact probabilities in pThr55 and pSer46pThr55 tetramer, especially for the phosphorylated residues and neighboring charges. Contacts involving the PRD only show minor increases with pSer46 or pThr55. For the DBD, residue contact frequencies remain similar in all three p53 constructs (Figures S3B). The ability of HyRes to recapitulate these nontrivial PRE effects of pThr55 and pSer46 suggests that the simulated ensembles are likely realistic and biologically relevant, allowing further analysis of the molecular basis of phosphorylation regulation of p53 autoinhibition.

Phosphorylation promotes trans-dimer NTAD-DBD contacts to enhance autoinhibition

PCA was performed to further analyze the conformational distributions of the dynamic NTAD-DBD interactions within each of the three p53 tetramer constructs. For this, we first derived two common principal components (PCs) using snapshots collected from all three sets of HyRes simulations (see Methods). The results show that, for the wild-type p53 tetramer, the conformational space is predominantly occupied by cis-like states (Figure 5A and Figure S4). That is, in the absence of phosphorylation, the NTAD and DBD interact primarily within the same dimer (cis). Whereas in the pThr55 p53 tetramer, there is a shift in the conformational equilibrium towards more states where NTADs from one dimer interacts DBDs from the other dimer (trans) (Figure 5B and Figure S5). Among the 7 major basins of pThr55 p53 tetramer, only one is cis-like and the rest is either mixed (both cis and trans interactions present) or trans-like. The shift towards trans-like states is even more prominent in the pSer46/pThr55 p53 tetramer, where the population of trans-like and mixed states continue to increase (Figure 5C and Figure S6). Taken together, the simulated ensembles provide a direct support at the molecular level for the proposal that phosphorylation of Thr55 and Ser46 may promote the trans-like NTAD-DBD interaction within the p53 tetramer to further strengthen autoinhibition42.

Figure 5. PCA analysis of dynamic NTAD-DBD interactions in various p53 tetramer constructs.

Figure 5.

(A) Wild-type p53 tetramer, where all major states are cis-like. B) pThr55 p53 tetramer, where new states with trans NTAD-DBD interactions start emerging. For the 7 major basins shown, states 1, 3, 4 are trans-like, states 2, 6, and 7 are mixed, and only state 5 is cis-like. (C) pSer46pThr55 p53 tetramer, where there is a further increase in populations of trans-like states. With the 9 major basins, states 1, 3, 5, 7, and 9 are trans-like, states 4, 6, and 8 are mixed, and states 2 and 6 are cis-like. For the representative snapshots, DBDs of two dimers are shown in yellow and gray. Only one of the NTADs from the gray dimer is shown in red cartoon for clarity. Locations of (p)Thr55 and (p)Ser46 are marked using green spheres and paramagnetic spin labelling site S121with yellow beads. Contours are drawn at every kT. See Figure S46 for representative snapshots for all major basins of all three p53 constructs.

Conclusion

In this study, we have extended the HyRes protein force field to model phosphorylated side chains and demonstrated the capability of the force field to generate biologically relevant dynamic conformational ensembles of the p53 tetramer. The simulated ensembles correctly recapitulate nontrivial effects of pThr55 and pSer46 on local structures and transient long-range interactions between NTAD and DBD, providing new insights into how phosphorylation modulates the disordered conformational equilibrium in p53 autoinhibition. Specifically, pThr55 and pSer46 do not only enhance the association of the AD2 region with the DNA binding interface of DBD, through nonspecific electrostatic interactions, but further promote the trans interaction mode where NTADs from one dimer preferentially engage with DBDs from the other dimer of the p53 tetramer. The conformational shift towards the trans mode further stabilizes the DNA-unbound state of p53 tetramer and strengthens autoinhibition. The current work also supports the potential of HyRes as a powerful tool for studying the conformational landscapes and dynamic interactions of IDPs in physiological and pathological pathways.

Supplementary Material

Final SI

Supplementary figures showing the initial conformations, error bars of calculated PRE profiles, contact probabilities, and illustration of NTAD-DBD interactions of all major states or various p53 tetramer constructs. The online version contains supplementary material available at https://doi.org/xxxx

Acknowledgements

The authors thank Juni Campbell and Dr. Shanlong Li for useful discussions. This work is supported by NIH R35 GM144045 (to Chen).

Footnotes

Competing interests

The authors declare no competing interests.

Reference

  • (1).Wright PE, and Dyson HJ (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. Journal of Molecular Biology 293, 321–331. [DOI] [PubMed] [Google Scholar]
  • (2).Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, and Dunker AK (2001) Sequence complexity of disordered protein. Proteins: Structure, Function, and Bioinformatics 42, 38–48. [DOI] [PubMed] [Google Scholar]
  • (3).Chen J (2012) Towards the physical basis of how intrinsic disorder mediates protein function. Archives of Biochemistry and Biophysics 524, 123–131. [DOI] [PubMed] [Google Scholar]
  • (4).Uversky VN, Davé V, Iakoucheva LM, Malaney P, Metallo SJ, Pathak RR, and Joerger AC (2014) Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human Diseases. Chem. Rev 114, 6844–6879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).Dunker AK, Cortese MS, Romero P, Iakoucheva LM, and Uversky VN (2005) Flexible nets. The FEBS Journal 272, 5129–5148. [DOI] [PubMed] [Google Scholar]
  • (6).Wright PE, and Dyson HJ (2009) Linking folding and binding. Current Opinion in Structural Biology 19, 31–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (7).Rogers JM, Oleinikovas V, Shammas SL, Wong CT, De Sancho D, Baker CM, and Clarke J (2014) Interplay between partner and ligand facilitates the folding and binding of an intrinsically disordered protein. Proceedings of the National Academy of Sciences 111, 15420–15425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (8).Wright PE, and Dyson HJ (2015) Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol 16, 18–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Miskei M, Antal C, and Fuxreiter M (2017) FuzDB: database of fuzzy complexes, a tool to develop stochastic structure-function relationships for protein complexes and higher-order assemblies. Nucleic Acids Research 45, D228–D235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Clark S, Myers JB, King A, Fiala R, Novacek J, Pearce G, Heierhorst J, Reichow SL, and Barbar EJ (2018) Multivalency regulates activity in an intrinsically disordered transcription factor. eLife (Kay LE, Ed.) 7, e36258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (11).Fuxreiter M (2018) Fuzziness in Protein Interactions—A Historical Perspective. Journal of Molecular Biology 430, 2278–2287. [DOI] [PubMed] [Google Scholar]
  • (12).Weng J, and Wang W (2020) Dynamic multivalent interactions of intrinsically disordered proteins. Current Opinion in Structural Biology 62, 9–13. [DOI] [PubMed] [Google Scholar]
  • (13).Gianni S, Freiberger MI, Jemth P, Ferreiro DU, Wolynes PG, and Fuxreiter M (2021) Fuzziness and Frustration in the Energy Landscape of Protein Folding, Function, and Assembly. Acc. Chem. Res 54, 1251–1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Zhao J, Liu X, Blayney A, Zhang Y, Gandy L, Mirsky PO, Smith N, Zhang F, Linhardt RJ, Chen J, Baines C, Loh SN, and Wang C (2022) Intrinsically Disordered N-terminal Domain (NTD) of p53 Interacts with Mitochondrial PTP Regulator Cyclophilin D. Journal of Molecular Biology 434, 167552. [DOI] [PubMed] [Google Scholar]
  • (15).Boehr DD, Nussinov R, and Wright PE (2009) The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 5, 789–796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (16).Smock RG, and Gierasch LM (2009) Sending Signals Dynamically. Science 324, 198–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).White JT, Li J, Grasso E, Wrabl JO, and Hilser VJ (2018) Ensemble allosteric model: energetic frustration within the intrinsically disordered glucocorticoid receptor. Philosophical Transactions of the Royal Society B: Biological Sciences 373, 20170175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (18).Chen J, Liu X, and Chen J (2020) Targeting Intrinsically Disordered Proteins through Dynamic Interactions. Biomolecules 10, 743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (19).Garcia-Pino A, Balasubramanian S, Wyns L, Gazit E, De Greve H, Magnuson RD, Charlier D, van Nuland NAJ, and Loris R (2010) Allostery and Intrinsic Disorder Mediate Transcription Regulation by Conditional Cooperativity. Cell 142, 101–111. [DOI] [PubMed] [Google Scholar]
  • (20).Ferreon ACM, Ferreon JC, Wright PE, and Deniz AA (2013) Modulation of allostery by protein intrinsic disorder. Nature 498, 390–394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Berlow RB, Dyson HJ, and Wright PE (2018) Expanding the Paradigm: Intrinsically Disordered Proteins and Allosteric Regulation. Journal of Molecular Biology 430, 2309–2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (22).Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, and Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26, 2157–2165. [DOI] [PubMed] [Google Scholar]
  • (23).Hollstein M, Sidransky D, Vogelstein B, and Harris CC (1991) p53 Mutations in Human Cancers. Science 253, 49–53. [DOI] [PubMed] [Google Scholar]
  • (24).Joerger AC, and Fersht AR (2008) Structural Biology of the Tumor Suppressor p53. Annual Review of Biochemistry 77, 557–582. [DOI] [PubMed] [Google Scholar]
  • (25).Lavin MF, and Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13, 941–950. [DOI] [PubMed] [Google Scholar]
  • (26).Kruse J-P, and Gu W (2009) Modes of p53 Regulation. Cell 137, 609–622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (27).Teufel DP, Bycroft M, and Fersht AR (2009) Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene 28, 2112–2118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).Lee CW, Ferreon JC, Ferreon ACM, Arai M, and Wright PE (2010) Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proceedings of the National Academy of Sciences 107, 19290–19295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (29).Lowry DF, Stancik A, Shrestha RM, and Daughdrill GW (2008) Modeling the accessible conformations of the intrinsically unstructured transactivation domain of p53. Proteins: Structure, Function, and Bioinformatics 71, 587–598. [DOI] [PubMed] [Google Scholar]
  • (30).Wells M, Tidow H, Rutherford TJ, Markwick P, Jensen MR, Mylonas E, Svergun DI, Blackledge M, and Fersht AR (2008) Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proceedings of the National Academy of Sciences 105, 5762–5767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (31).Huang F, Rajagopalan S, Settanni G, Marsh RJ, Armoogum DA, Nicolaou N, Bain AJ, Lerner E, Haas E, Ying L, and Fersht AR (2009) Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer. Proceedings of the National Academy of Sciences 106, 20758–20763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Lum JK, Neuweiler H, and Fersht AR (2012) Long-Range Modulation of Chain Motions within the Intrinsically Disordered Transactivation Domain of Tumor Suppressor p53. J. Am. Chem. Soc 134, 1617–1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Liu X, and Chen J (2019) Residual Structures and Transient Long-Range Interactions of p53 Transactivation Domain: Assessment of Explicit Solvent Protein Force Fields. J. Chem. Theory Comput 15, 4708–4720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (34).Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, and Pavletich NP (1996) Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain. Science 274, 948–953. [DOI] [PubMed] [Google Scholar]
  • (35).Di Lello P, Jenkins LMM, Jones TN, Nguyen BD, Hara T, Yamaguchi H, Dikeakos JD, Appella E, Legault P, and Omichinski JG (2006) Structure of the Tfb1/p53 Complex: Insights into the Interaction between the p62/Tfb1 Subunit of TFIIH and the Activation Domain of p53. Molecular Cell 22, 731–740. [DOI] [PubMed] [Google Scholar]
  • (36).Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, and Wright PE (2009) Mapping the Interactions of the p53 Transactivation Domain with the KIX Domain of CBP. Biochemistry 48, 2115–2124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (37).Lee CW, Martinez-Yamout MA, Dyson HJ, and Wright PE (2010) Structure of the p53 Transactivation Domain in Complex with the Nuclear Receptor Coactivator Binding Domain of CREB Binding Protein. Biochemistry 49, 9964–9971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (38).Ganguly D, and Chen J (2015) Modulation of the Disordered Conformational Ensembles of the p53 Transactivation Domain by Cancer-Associated Mutations. PLOS Computational Biology 11, e1004247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (39).Schrag LG, Liu X, Thevarajan I, Prakash O, Zolkiewski M, and Chen J (2021) Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain. Journal of Molecular Biology 433, 167048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (40).Krois AS, Dyson HJ, and Wright PE (2018) Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain. Proceedings of the National Academy of Sciences 115, E11302–E11310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (41).He F, Borcherds W, Song T, Wei X, Das M, Chen L, Daughdrill GW, and Chen J (2019) Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding. Proceedings of the National Academy of Sciences 116, 8859–8868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (42).Sun X, Dyson HJ, and Wright PE (2021) A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding. Proceedings of the National Academy of Sciences 118, e2021456118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (43).Gatti A, Li H-H, Traugh JA, and Liu X (2000) Phosphorylation of Human p53 on Thr-55. Biochemistry 39, 9837–9842. [DOI] [PubMed] [Google Scholar]
  • (44).Li H-H, Li AG, Sheppard HM, and Liu X (2004) Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53: A Role for TAF1 in Cell G1 Progression. Molecular Cell 13, 867–878. [DOI] [PubMed] [Google Scholar]
  • (45).Cai X, and Liu X (2008) Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage. Proceedings of the National Academy of Sciences 105, 16958–16963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (46).Wu Y, Lin JC, Piluso LG, Dhahbi JM, Bobadilla S, Spindler SR, and Liu X (2014) Phosphorylation of p53 by TAF1 Inactivates p53-Dependent Transcription in the DNA Damage Response. Molecular Cell 53, 63–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (47).Ganguly D, and Chen J (2009) Atomistic Details of the Disordered States of KID and pKID. Implications in Coupled Binding and Folding. J. Am. Chem. Soc 131, 5214–5223. [DOI] [PubMed] [Google Scholar]
  • (48).Mao AH, Crick SL, Vitalis A, Chicoine CL, and Pappu RV (2010) Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proceedings of the National Academy of Sciences 107, 8183–8188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (49).Knott M, and Best RB (2012) A Preformed Binding Interface in the Unbound Ensemble of an Intrinsically Disordered Protein: Evidence from Molecular Simulations. PLOS Computational Biology 8, e1002605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (50).Zhang W, Ganguly D, and Chen J (2012) Residual Structures, Conformational Fluctuations, and Electrostatic Interactions in the Synergistic Folding of Two Intrinsically Disordered Proteins. PLOS Computational Biology 8, e1002353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (51).Levine ZA, and Shea J-E (2017) Simulations of disordered proteins and systems with conformational heterogeneity. Current Opinion in Structural Biology 43, 95–103. [DOI] [PubMed] [Google Scholar]
  • (52).Gong X, Zhang Y, and Chen J (2021) Advanced Sampling Methods for Multiscale Simulation of Disordered Proteins and Dynamic Interactions. Biomolecules 11, 1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (53).Liu X, and Chen J (2017) HyRes: a coarse-grained model for multi-scale enhanced sampling of disordered protein conformations. Phys. Chem. Chem. Phys 19, 32421–32432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (54).Zhang Y, Liu X, and Chen J (2022) Toward Accurate Coarse-Grained Simulations of Disordered Proteins and Their Dynamic Interactions. J. Chem. Inf. Model 62, 4523–4536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (55).Zhang Y, Li S, Gong X, and Chen J (2024) Toward Accurate Simulation of Coupling between Protein Secondary Structure and Phase Separation. J. Am. Chem. Soc 146, 342–357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (56).Shorkey SA, Zhang Y, Sharp J, Clingman S, Nguyen L, Chen J, and Chen M (2024, May 15) Tuning single-molecule ClyA nanopore tweezers for real-time tracking of the conformational dynamics of West Nile viral NS2B/NS3 protease. bioRxiv. [Google Scholar]
  • (57).MacKerell AD Jr., Bashford D, Bellott M, Dunbrack RL Jr., Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiórkiewicz-Kuczera J, Yin D, and Karplus M (1998) All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins. J. Phys. Chem. B 102, 3586–3616. [DOI] [PubMed] [Google Scholar]
  • (58).Chen J, Im W, and Brooks CL (2006) Balancing Solvation and Intramolecular Interactions: Toward a Consistent Generalized Born Force Field. J. Am. Chem. Soc 128, 3728–3736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (59).Chen Y, Dey R, and Chen L (2010) Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self-Assembled Tetramer. Structure 18, 246–256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (60).Brooks BR, Brooks CL III, Mackerell AD Jr., Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, and Karplus M (2009) CHARMM: The biomolecular simulation program. Journal of Computational Chemistry 30, 1545–1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (61).Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, and Karplus M (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry 4, 187–217. [Google Scholar]
  • (62).Šali A, and Blundell TL (1993) Comparative Protein Modelling by Satisfaction of Spatial Restraints. Journal of Molecular Biology 234, 779–815. [DOI] [PubMed] [Google Scholar]
  • (63).Eastman P, Swails J, Chodera JD, McGibbon RT, Zhao Y, Beauchamp KA, Wang L-P, Simmonett AC, Harrigan MP, Stern CD, Wiewiora RP, Brooks BR, and Pande VS (2017) OpenMM 7: Rapid development of high performance algorithms for molecular dynamics. PLOS Computational Biology 13, e1005659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (64).Eastman P, Galvelis R, Peláez RP, Abreu CRA, Farr SE, Gallicchio E, Gorenko A, Henry MM, Hu F, Huang J, Krämer A, Michel J, Mitchell JA, Pande VS, Rodrigues JP, Rodriguez-Guerra J, Simmonett AC, Singh S, Swails J, Turner P, Wang Y, Zhang I, Chodera JD, De Fabritiis G, and Markland TE (2024) OpenMM 8: Molecular Dynamics Simulation with Machine Learning Potentials. J. Phys. Chem. B 128, 109–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (65).Ryckaert J-P, Ciccotti G, and Berendsen HJC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal of Computational Physics 23, 327–341. [Google Scholar]
  • (66).Michaud-Agrawal N, Denning EJ, Woolf TB, and Beckstein O (2011) MDAnalysis: A toolkit for the analysis of molecular dynamics simulations. Journal of Computational Chemistry 32, 2319–2327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (67).McGibbon RT, Beauchamp KA, Harrigan MP, Klein C, Swails JM, Hernández CX, Schwantes CR, Wang L-P, Lane TJ, and Pande VS (2015) MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories. Biophysical Journal 109, 1528–1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (68).Kabsch W, and Sander C (1983) Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577–2637. [DOI] [PubMed] [Google Scholar]
  • (69).Pedregosa F, Pedregosa F, Varoquaux G, Varoquaux G, Org N, Gramfort A, Gramfort A, Michel V, Michel V, Fr L, Thirion B, Thirion B, Grisel O, Grisel O, Blondel M, Prettenhofer P, Prettenhofer P, Weiss R, Dubourg V, Dubourg V, Vanderplas J, Passos A, Tp A, and Cournapeau D Scikit-learn: Machine Learning in Python. MACHINE LEARNING IN PYTHON. [Google Scholar]
  • (70).Humphrey W, Dalke A, and Schulten K (1996) VMD: Visual molecular dynamics. Journal of Molecular Graphics 14, 33–38. [DOI] [PubMed] [Google Scholar]
  • (71).Robustelli P, Piana S, and Shaw DE (2018) Developing a molecular dynamics force field for both folded and disordered protein states. Proceedings of the National Academy of Sciences 115, E4758–E4766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (72).Iwahara J, Tang C, and Marius Clore G (2007) Practical aspects of 1H transverse paramagnetic relaxation enhancement measurements on macromolecules. Journal of Magnetic Resonance 184, 185–195. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Final SI

RESOURCES